$50 BILLION DOLLARS. Gone. In a single trading session.

Yesterday, Novo Nordisk—the company behind Ozempic and Wegovy, the company that basically invented the weight loss drug revolution—watched 18% of its market value disappear in hours.

But here's what makes this story wild. After the crash, their new CEO got in front of investors and said: "People should expect that it goes down before it comes back up."

He told them it gets worse from here.

Today's Show:

• The Crash: $50B wiped out, 18% drop, guidance 10x worse than expected
• The Trump Factor: TrumpRx forced an 85% price cut on Wegovy
• The Competition: Eli Lilly's next-gen drug showing 28.7% weight loss
• The Knockoffs: Compounding pharmacies selling semaglutide for $200 vs $1,000
• The Leadership Shakeup: New CEO, US chief leaving, former CEO back as chairman
• The Denmark Problem: One company = 40% of the Copenhagen Stock Exchange
• Bull vs Bear Case: Volume play or falling knife?

Key Numbers:

• Stock drop: 18% in one day
• 2025 performance: Down 50%
• Guidance: Sales DOWN 5-13% (analysts expected -1.4%)
• Wegovy pill signups: 170,000 in first 4 weeks
• Price cut: $1,000/month → $149/month (85% reduction)
• Eli Lilly next-gen results: 28.7% average weight loss

Sources Referenced:

• CNBC: Novo Nordisk Stock Crashes on 2026 Guidance
• Reuters: Novo Nordisk Issues Bleak 2026 Forecast
• Reuters: Trump Obesity Drug Deal with Novo and Lilly
• Reuters: Lilly's Next-Gen Drug Tops Zepbound in Trials
• Yahoo Finance: Novo Nordisk Shares Tumble 18%
• Euronews: Novo Nordisk Stock Sinks After Bleak Forecast

CEO Quotes (Mike Doustdar):

• "People should expect that it goes down before it comes back up"
• "No matter how well the pill does, the price hit on the existing business trumps the great pill launch"
• "We are creating affordability for millions of patients who simply could not afford it"

Chapters:

• 00:00 - The $50 Billion Crash
• 01:15 - What Is Novo Nordisk?
• 02:30 - The Catastrophic 2026 Guidance
• 03:45 - CEO Says "It Gets Worse"
• 05:00 - The Trump Factor: 85% Price Cut
• 06:30 - Eli Lilly Is Winning
• 08:00 - Compounding Pharmacies
• 09:00 - Leadership Shakeup
• 10:00 - The Denmark Problem
• 11:00 - What Analysts Are Saying
• 12:00 - Bull Case vs Bear Case
• 14:30 - What To Watch
• 15:45 - Final Thoughts

Follow the Show:

Website: moneymen.fm

Tools We Use:

→ TradingView: Get TradingView (Charts & analysis)

Some links above support the show at no extra cost to you.

• (00:00) - The $50 Billion Crash
• (01:15) - What Is Novo Nordisk?
• (02:30) - The Catastrophic 2026 Guidance
• (03:45) - CEO Says It Gets Worse
• (05:00) - The Trump Factor: 85% Price Cut
• (06:30) - Eli Lilly Is Winning
• (08:00) - Compounding Pharmacies
• (09:00) - Leadership Shakeup
• (10:00) - The Denmark Problem
• (11:00) - What Analysts Are Saying
• (12:00) - Bull Case vs Bear Case
• (14:30) - What To Watch
• (15:45) - Final Thoughts